dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers.
Hepatocellular carcinoma (HCC), which is associated with an absence of obvious symptoms and poor prognosis, is the second leading cause of cancer death worldwide. Genome-wide molecular biology studies should provide biological insights into HCC development. Based on the importance of phosphorylation...
Main Authors: | Yen-Wei Chu, Ching-Hsuan Chien, Mei-I Sung, Chi-Wei Chen, Yu-Ting Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0234084 |
Similar Items
-
HCC Biomarkers in China and Taiwan
by: Regina M. Santella
Published: (2007-02-01) -
Exploration of new HCC biomarkers
by: Regina M. Santella
Published: (2007-02-01) -
An Overview of Biomarkers and Molecular Signatures in HCC
by: Seon-Hee Yim, et al.
Published: (2010-05-01) -
Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment
by: Mengtao Xing, et al.
Published: (2021-06-01) -
Foamy Histiocyte-Like Hepatocellular Carcinoma (HCC): A New Variant of HCC?
by: Richard Dunn, et al.
Published: (2017-03-01)